Concepedia

The relationship between intact PTH and biointact PTH (1–84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD)

D. O’Flaherty, A. Sankaralingam, Paul Scully, P. Manghat, David Goldsmith, Geeta Hampson

Clinical Biochemistry · 2013 · 20 citations · 18 references

DOI

Concepts

References

18

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

Shaul G. Massry, Jack W. Coburn, Glenn M. Chertow et al. · Data Archiving and Networked Services (DANS) · 2003 · 2.5K citations

, , +16

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)

Alison M. MacLeod · Kidney International · 2009 · 2.2K citations

, , +16

Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

Sharon M. Moe, Tilman B. Drüeke, John Cunningham et al. · Kidney International · 2006 · 2K citations

, , +16

A novel mechanism for skeletal resistance in uremia

Eduardo Slatopolsky, Jane Finch, Patricia Clay et al. · Kidney International · 2000 · 424 citations

, , +14

A non-(1–84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples

Raymond Lepage, Louise Roy, Jean‐Hugues Brossard et al. · Clinical Chemistry · 1998 · 365 citations

, , +13